EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors

Chuankai Chen iD, Ya-Ping Jiang, Inchul You, Nathanael S Gray, Richard Z Lin

Cells · 2024

DOI: 10.3390/cells13121061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Chuankai Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Biophysics, Stony Brook University, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Pancreatic Neoplasms, Down-Regulation, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serine/threonine kinase AKT isoforms play a well-established role in cell metabolism and growth. Most pancreatic adenocarcinomas (PDACs) harbor activation mutations of KRAS, which activates the PI3K/AKT signaling pathway. However, AKT inhibitors are not effective in the treatment of pancreatic cancer. To better understand the role of AKT signaling in mutant-KRAS pancreatic tumors, this study utilized proteolysis-targeting chimeras (PROTACs) and CRISPR-Cas9-genome editing to investigate AKT proteins. The PROTAC down-regulation of AKT proteins markedly slowed the growth of three pancreatic tumor cell lines harboring mutant KRAS. In contrast, the inhibition of AKT kinase activity alone had very little effect on the growth of these cell lines. The concurrent genetic deletion of all AKT isoforms (AKT1, AKT2, and AKT3) in the KPC (KrasG12D; Trp53R172H; Pdx1-Cre) pancreatic cancer cell line also dramatically slowed its growth in vitro and when orthotopically implanted in syngeneic mice. Surprisingly, insulin-like growth factor-1 (IGF-1), but not epidermal growth factor (EGF), restored KPC cell growth in serum-deprived conditions, and the IGF-1 growth stimulation effect was AKT-dependent. The RNA-seq analysis of AKT1/2/3-deficient KPC cells suggested that reduced cholesterol synthesis may be responsible for the decreased response to IGF-1 stimulation. These results indicate that the presence of all three AKT isoforms supports pancreatic tumor cell growth, and the pharmacological degradation of AKT proteins may be more effective than AKT catalytic inhibitors for treating pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktPancreatic NeoplasmsDown-RegulationProto-Oncogene Proteins p21(ras)MutationAnimalsCell Line, TumorMiceHumansCell ProliferationSignal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AKTIGF-1cholesterol metabolismpancreatic cancer

Substanzen

Proto-Oncogene Proteins c-aktProto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Physiology & Biophysics, Stony Brook University, Stony Brook, NY 11794, USA.
  • Graduate Program in Genetics, Stony Brook University, Stony Brook, NY 11790, USA.
  • Department of Chemical and Systems Biology, ChEM-H, and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Northport VA Medical Center, Northport, NY 11768, USA.

ORCID-Profile: Chuankai Chen

Förderung

  • BLRD VA
  • NCI NIH HHS
  • NIH HHS
  • Department of Veterans Affairs Merit Review
  • National Institute of Health

Zitieren

APA

Chen, C., Jiang, Y. P., You, I., Gray, N. S., & Lin, R. Z. (2024). Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors. Cells. https://doi.org/10.3390/cells13121061

Vancouver

Chen C, Jiang YP, You I, Gray NS, Lin RZ. Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors. Cells. 2024. doi:10.3390/cells13121061

BibTeX
@article{Chen2024,
  author = {Chen, Chuankai and Jiang, Ya-Ping and You, Inchul and Gray, Nathanael S and Lin, Richard Z},
  title = {Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13121061}
}
Kostenlos starten →